Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Alignment Healthcare, Inc. (ALHC)

21.86 +0.44 (+2.05%)
At close: June 18 at 4:00:00 PM EDT
21.63 -0.23 (-1.05%)
After hours: June 18 at 7:38:19 PM EDT
Trade ALHC on Coinbase
Chart Range Bar
Loading chart for ALHC
Chart does not reflect overnight price.
  • Previous Close 21.42
  • Open 21.31
  • Bid 15.90 x 200
  • Ask 27.67 x 200
  • Day's Range 21.28 - 22.38
  • 52 Week Range 11.62 - 23.87
  • Volume 6,639,050
  • Avg. Volume 5,461,168
  • Market Cap (intraday) 4.519B
  • Beta (5Y Monthly) 1.15
  • PE Ratio (TTM) 218.60
  • EPS (TTM) 0.10
  • Earnings Date (est.) Jul 30, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 24.92

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

www.alignmenthealth.com

1,849

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Performance Overview

Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ALHC
10.68%
S&P 500 (^GSPC)
9.57%

1-Year Return

ALHC
51.81%
S&P 500 (^GSPC)
25.41%

3-Year Return

ALHC
252.58%
S&P 500 (^GSPC)
70.10%

5-Year Return

ALHC
18.43%
S&P 500 (^GSPC)
80.02%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 1.24B
Earnings 25.87M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
200M
400M
600M
800M
1B
1B

Analyst Insights

View More

Analyst Price Targets

16.00 Low
24.92 Average
21.86 Current
30.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/26/2026
Analyst Barclays
Rating Action Maintains
Rating Equal-Weight
Price Action Lowers
Price Target 19 -> 16

Statistics

View More

Valuation Measures

Annual
As of 6/17/2026
  • Market Cap

    4.43B

  • Enterprise Value

    4.03B

  • Trailing P/E

    214.20

  • Forward P/E

    204.08

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.02

  • Price/Book (mrq)

    21.40

  • Enterprise Value/Revenue

    0.95

  • Enterprise Value/EBITDA

    60.68

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.47%

  • Return on Assets (ttm)

    2.11%

  • Return on Equity (ttm)

    12.53%

  • Revenue (ttm)

    4.26B

  • Net Income Avi to Common (ttm)

    19.81M

  • Diluted EPS (ttm)

    0.10

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    726.29M

  • Total Debt/Equity (mrq)

    159.49%

  • Levered Free Cash Flow (ttm)

    234.58M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

21.86 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Raising target price to $22.00

    Alignment Healthcare Inc has an Investment Rating of HOLD; a target price of $22.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
  • Raising target price to $20.00

    Alignment Healthcare Inc has an Investment Rating of HOLD; a target price of $20.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Lowering target price to $13.00

    Alignment Healthcare Inc has an Investment Rating of HOLD; a target price of $13.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
  • Lowering target price to $15.00

    Alignment Healthcare Inc has an Investment Rating of HOLD; a target price of $15.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: